Patents by Inventor Michal SEGAL SALTO

Michal SEGAL SALTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATMENT USING ANTI-CCL24 ANTIBODY
    Publication number: 20230235037
    Abstract: Provided are compositions and methods for treating fibrotic inflammatory diseases, including non-alcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc), with an anti-CCL24 monoclonal antibody.
    Type: Application
    Filed: April 20, 2021
    Publication date: July 27, 2023
    Applicant: CHEMOMAB LTD.
    Inventors: Adi MOR, Arnon AHARON, Sharon HASHMUELI, Michal SEGAL SALTO, Neta BARASHI
  • CCL24 INHIBITORS IN THE TREATMENT OF COVID-19
    Publication number: 20230192836
    Abstract: The invention concerns isolated monoclonal antibodies that bind to CCL24 (eotaxin 2) for use in the treatment of Covid-19.
    Type: Application
    Filed: April 20, 2021
    Publication date: June 22, 2023
    Applicant: CHEMOMAB LTD.
    Inventors: Adi MOR, Arnon AHARON, Michal SEGAL SALTO, Neta BARASHI